The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Scrip dividend share allotment - Replacement

10 Jan 2024 10:15

RNS Number : 2597Z
NewRiver REIT PLC
10 January 2024
 

 

 

NewRiver REIT plc

 

("NewRiver" or the "Company")

 

The headline for the NewRiver REIT plc's announcement released on 10/01/24 at 09.28 under RNS No 2543Z should read Scrip dividend share allotment

 

The announcement text is unchanged and is reproduced in full below.

Scrip dividend share allotment

Application has been made to the Financial Conduct Authority and the London Stock Exchange Plc for a total of 818,581 Ordinary Shares of 1p each ('Shares') to be admitted to the Official List.

Admission of the Shares is expected on 15 January 2024.

The Shares are being issued in respect of elections to participate in the Scrip Dividend Scheme in respect of the interim dividend for the six months ended 30 September 2023.

The Shares will rank pari passu with the existing Ordinary Shares.

Ends

 

For further information

 

NewRiver REIT plc

+44 (0)20 3328 5800

Kerin Williams (Company Secretary)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURARRSOUAAAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.